Join the stroke patient support group and stay updated on stem cell clinical trials!


2020-11-05

To create a friendly platform for meaningful交流, we’ve established a stroke patient support group, making it easier for everyone to stay updated on stem cell clinical trial information, share their conditions, and learn from each other’s experiences.

In February 2020, Jiuzhitang Maker’s clinical trial for a new stem-cell drug received approval—marking the first clinical trial to utilize imported stem cells, the first to target a major neurological indication with stem-cell therapy, and also the first trial—following the National Medical Products Administration’s resumption of accepting applications for stem-cell clinical trials—to employ bone marrow-derived mesenchymal stem cells.

To create a friendly platform for meaningful交流, we’ve established a stroke patient support group, making it easier for everyone to stay updated on stem cell clinical trial information, share their conditions, and learn from each other’s experiences.